Schering-Plough’s “Faster” Claims For Lotrimin Ultra Not Accurate – NAD
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough Healthcare Products should modify claims that its Lotrimin Ultra relieves athlete's foot in less time than Novartis Consumer Healthcare's Lamisil Defense, the National Advertising Division recommends